Reduction Efficacy of OLOMAX for Blood Pressure and Low-density Lipoprotein Cholesterol in Hypertensive Patients With Dyslipidemia

Más betegség

• A person who has a history of administering olomax tablets before participating in this study

Egyéb

• A person who falls under the prohibition of administration according to the permission for olomax tablet
• In addition to the above, a person that the investigator thinks he/she is not suitable for participating in this observation study;

• Adult aged 19 or older at the time of the baseline visit.
• A patient with hypertension and dyslipidemia who is scheduled to administer olomax tablet according to investigator's medical judgement.
  • Patients who were previously taking more than two tablets of a single drug, low-density lipoprotein-cholesterol (LDL-C)
  • Patients who were previously only taking blood pressure-lowering drugs and did not take LDL-C-lowering drugs, but who need to take additional LDL-C-lowering drugs at the discretion of the researcher
  • Patients who were previously taking LDL-C lowering agents and did not take blood pressure lowering agents, but who need to take additional blood pressure lowering agents according to the researcher's judgment
  • Patients who have not previously taken both a blood pressure drop and an LDL-C drop but need additional simultaneous use at the discretion of the researcher
• A person who can understand the information provided to him/her and may voluntarily sign a written consent form